240 related articles for article (PubMed ID: 7585125)
1. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3.
Wales MM; Biel MA; el Deiry W; Nelkin BD; Issa JP; Cavenee WK; Kuerbitz SJ; Baylin SB
Nat Med; 1995 Jun; 1(6):570-7. PubMed ID: 7585125
[TBL] [Abstract][Full Text] [Related]
2. Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer.
Nicoll G; Crichton DN; McDowell HE; Kernohan N; Hupp TR; Thompson AM
Br J Cancer; 2001 Dec; 85(12):1878-82. PubMed ID: 11747329
[TBL] [Abstract][Full Text] [Related]
3. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer.
Fujii H; Biel MA; Zhou W; Weitzman SA; Baylin SB; Gabrielson E
Oncogene; 1998 Apr; 16(16):2159-64. PubMed ID: 9572497
[TBL] [Abstract][Full Text] [Related]
5. [Chromosome arm 17p13.3: could HIC1 be the one ?].
Chopin V; Leprince D
Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
[TBL] [Abstract][Full Text] [Related]
6. Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53.
Guerardel C; Deltour S; Pinte S; Monte D; Begue A; Godwin AK; Leprince D
J Biol Chem; 2001 Feb; 276(5):3078-89. PubMed ID: 11073960
[TBL] [Abstract][Full Text] [Related]
7. Evolutionary divergence in the broad complex, tramtrack and bric à brac/poxviruses and zinc finger domain from the candidate tumor suppressor gene hypermethylated in cancer.
Guerardel C; Deltour S; Leprince D
FEBS Lett; 1999 May; 451(3):253-6. PubMed ID: 10371200
[TBL] [Abstract][Full Text] [Related]
8. The carboxy-terminal end of the candidate tumor suppressor gene HIC-1 is phylogenetically conserved.
Deltour S; Guerardel C; Stehelin D; Leprince D
Biochim Biophys Acta; 1998 Nov; 1443(1-2):230-2. PubMed ID: 9838134
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma.
Rood BR; Zhang H; Weitman DM; Cogen PH
Cancer Res; 2002 Jul; 62(13):3794-7. PubMed ID: 12097291
[TBL] [Abstract][Full Text] [Related]
10. Identification and functional characterization of a novel unspliced transcript variant of HIC-1 in human cancer cells exposed to adverse growth conditions.
Mondal AM; Chinnadurai S; Datta K; Chauhan SS; Sinha S; Chattopadhyay P
Cancer Res; 2006 Nov; 66(21):10466-77. PubMed ID: 17079468
[TBL] [Abstract][Full Text] [Related]
11. KRAB-independent suppression of neoplastic cell growth by the novel zinc finger transcription factor KS1.
Gebelein B; Fernandez-Zapico M; Imoto M; Urrutia R
J Clin Invest; 1998 Dec; 102(11):1911-9. PubMed ID: 9835615
[TBL] [Abstract][Full Text] [Related]
12. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV
Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695
[TBL] [Abstract][Full Text] [Related]
13. Induction of cell growth regulatory genes by p53.
Madden SL; Galella EA; Riley D; Bertelsen AH; Beaudry GA
Cancer Res; 1996 Dec; 56(23):5384-90. PubMed ID: 8968090
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes.
Theile M; Hartmann S; Scherthan H; Arnold W; Deppert W; Frege R; Glaab F; Haensch W; Scherneck S
Oncogene; 1995 Feb; 10(3):439-47. PubMed ID: 7845668
[TBL] [Abstract][Full Text] [Related]
15. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.
Britschgi C; Rizzi M; Grob TJ; Tschan MP; Hügli B; Reddy VA; Andres AC; Torbett BE; Tobler A; Fey MF
Oncogene; 2006 Mar; 25(14):2030-9. PubMed ID: 16301995
[TBL] [Abstract][Full Text] [Related]
16. Role of gut-enriched Krüppel-like factor in colonic cell growth and differentiation.
Shie JL; Chen ZY; O'Brien MJ; Pestell RG; Lee ME; Tseng CC
Am J Physiol Gastrointest Liver Physiol; 2000 Oct; 279(4):G806-14. PubMed ID: 11005769
[TBL] [Abstract][Full Text] [Related]
17. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
[TBL] [Abstract][Full Text] [Related]
18. topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.
Lin L; Ozaki T; Takada Y; Kageyama H; Nakamura Y; Hata A; Zhang JH; Simonds WF; Nakagawara A; Koseki H
Oncogene; 2005 May; 24(21):3385-96. PubMed ID: 15735665
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
20. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.
Driouch K; Prydz H; Monese R; Johansen H; Lidereau R; Frengen E
Oncogene; 2002 Mar; 21(12):1832-40. PubMed ID: 11896615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
